arrow
J

Jeffrey How

the university of texas m d anderson cancer center
H指数:20
被引数:1,274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial

依维莫司和来曲唑联合或不联合瑞博西尼在复发性子宫内膜癌中的疗效:一项2期随机临床试验

2026-09-010
OA
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium

副肾管样腺癌(MLA)的诊断标准与争议:MLA联盟病理学家的观点与指导

2026-01-012
PRE
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics

女性生殖道中肾样腺癌:病理诊断、临床结局及新型疗法

2025-06-010
PRE
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

帕博利珠单抗联合化疗在晚期卵巢癌一线治疗中的应用:一项II期临床试验的临床与转化研究结果

MED
IF11.8
2025-01-010
PRE
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors

复发成人型卵巢颗粒细胞瘤的连续细胞减灭术和生存结果

2024-05-013
OAAI
Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy
2024-03-220
PRE
Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics
2021-10-0151
PRE